Windlas Biotech Ltd

543329

Summary

Fair Value Assessment
Overvalued (15% Premium)
Fair ValueQ778.04UncertaintyHigh
Close Price900.50Jul 04, 2025
Market Closed
900.50
Price Down by 1.15 | 0.13 %
Previous Close
900.50
Day Range
898.35 – 917.65
Year Range
656.25 – 1,197.00
Bid / Ask
Market Cap
18.9 Bil
Volume / Average
4.5 k / 5.4 k
Beta (3-Year)
Shares Outstanding
20.96 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
Contact
Golf Course Extension Road 705-706, Vatika Professional Point, Gurgaon, HR 122 001
T +91 1242821030
www.windlas.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Mar 31, 2025
Fiscal Year End
Mar 31, 2025
Employees
1,154

Key Metrics

Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Income Statement (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Revenue
7.60 7.60 6.29 5.11 4.63 4.27
Revenue Growth %
20.43% 20.43% 23.17% 10.19% 8.59% 29.92%
Gross Profit
2.88 2.88 2.33 1.85 1.61 1.52
Gross Profit Margin %
37.90% 37.90% 37.00% 36.26% 34.65% 35.69%
Operating Income
0.66 0.66 0.65 0.48 0.41 0.44
Operating Margin %
8.70% 8.70% 10.29% 9.39% 8.76% 10.39%
EBIT
0.84 0.84 0.76 0.54 0.43 0.21
EBIT Margin %
11.07% 11.07% 12.12% 10.64% 9.21% 4.95%
EBITDA
1.12 1.12 0.90 0.67 0.55 0.34
EBITDA Margin %
14.76% 14.76% 14.26% 13.06% 11.84% 7.99%
Net Income
0.61 0.61 0.58 0.43 0.38 0.16
Net Profit Margin %
8.03% 8.03% 9.25% 8.35% 8.22% 3.65%
Basic EPS
29.19 29.19 27.97 19.70 18.58 7.26
Diluted EPS
28.87 28.87 27.88 19.70 18.58 7.26
Normalized EPS
Total Dividends per Share
5.50 5.50 4.00 3.50
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Balance Sheet (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Total Assets
7.60 7.60 6.26 5.29 4.91 2.96
Total Liabilities
2.55 2.55 1.76 1.27 0.96 0.97
Total Debt
0.33 0.33 0.04 0.05 0.07 0.32
Total Equity
5.06 5.06 4.50 4.02 3.95 1.99
Cash And Cash Equivalents
0.05 0.04 0.01 0.16
Working Capital
2.76 2.76 2.60 2.32 2.88 1.01
Shares Outstanding (Mil)
21.79 21.79
Book Value Per Share
241.31 241.31 213.98 190.88 180.31
Total Debt To Equity
0.06 0.06 0.01 0.01 0.02 0.16
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Cash Flow Statement (in Bil, except ratios)
03/31/2025
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
0.68 1.09 0.61 0.09 0.11 0.25
Cash From Investing Activities
-0.74 -0.92 -0.14 -1.55 -0.20 -0.14
Cash From Financing Activities
0.01 -0.15 -0.44 1.30 0.01 -0.05
Capital Expenditures
0.52 0.38 0.71 0.15 0.06 0.15
Free Cash Flow
0.21 0.26 -0.17 0.30 0.44 0.11
Change in Cash
-0.05 0.02 0.03 -0.15 -0.08 0.05

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
Oops!
Something went wrong.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
Oops!
Something went wrong.

Ownership

Ownership lists the Fund owners and Intitutional owners of the stock.
Name
Morningstar
Rating
% Total
Shares Held
% Total
Assets
Trend
Prev. 8 Qtrs
Current Shares
Change Amount
Change %
Date
ICICI Pru Pharma Healthcare Diag Gr Not Rated 4.09 1.42 857,651
0
0.00%
May 31, 2025
ICICI Pru Smallcap Gr 1.75 0.41 367,124
0
0.00%
May 31, 2025
UTI Healthcare Reg Gr Not Rated 0.72 1.30 151,215
1,539
1.03%
May 31, 2025
Avantis Emerging Markets Equity ETF 0.08 0.00 16,288
0
0.00%
Jun 28, 2025
Dimensional Emerging Core Equity Mkt ETF 0.02 0.00 4,727
0
0.00%
Jun 30, 2025
Total (for Top 5) 6.67 1,397,005
1,539

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top